Optimal Sequencing of EGFR-Targeted Therapy in Advanced EGFR+ Non-small cell lung cancer (NSCLC)
WebcastFaculty
OVERVIEW
Optimal Sequencing of EGFR-Targeted Therapy in Advanced EGFR+ Non-small cell lung cancer (NSCLC) is organized by prIME oncology Oncology and will be held during Apr 19, 2017 - Apr 19, 2018.
The target audience for this medical event is designed to meet the needs of community-based medical oncologists, nurses, fellows, pathologists, and other healthcare providers who treat and manage patients with lung cancer. This CME Conference has been approved for a maximum of 0.5 AMA PRA Category 1 Credits.
Conference Objectives are :
After completion of this educational activity, participants should be able to:
• Incorporate optimal molecular testing strategies, including liquid biopsy, for newly diagnosed and relapsed NSCLC
• Interpret and apply pathologic and molecular data in personalized treatment selection
• Identify mechanisms of action and efficacy/safety profiles of available and evolving therapies for acquired resistance to EGFR TKI therapy
Additional details will be posted as soon as they are available.
The target audience for this medical event is designed to meet the needs of community-based medical oncologists, nurses, fellows, pathologists, and other healthcare providers who treat and manage patients with lung cancer. This CME Conference has been approved for a maximum of 0.5 AMA PRA Category 1 Credits.
Conference Objectives are :
After completion of this educational activity, participants should be able to:
• Incorporate optimal molecular testing strategies, including liquid biopsy, for newly diagnosed and relapsed NSCLC
• Interpret and apply pathologic and molecular data in personalized treatment selection
• Identify mechanisms of action and efficacy/safety profiles of available and evolving therapies for acquired resistance to EGFR TKI therapy
Additional details will be posted as soon as they are available.
SPECIALITIES
Oncology
Quick Links